Session Information
2008 BIO International Convention
Click here to go to the previous page
Industry and Academia: Love Story or Dangerous Liaison
Track : Technology Transfer/Licensing
Program Code: 559
Date: Tuesday, June 17, 2008
Time: 8:15 AM to 9:45 AM  EST
Location: 29B
CHAIR :
Jonathan Soderstrom, PhD, Managing Director, President AUTM , Yale University, Office of Cooperative Research
SPEAKER (S):
Lily Chan, PhD, General Manager , Singapore Economic Development Board
Patrick Jones, AUTM Past President , Engineering Research Services, Arizona State University
Jan Lundberg, Executive VP, Discovery Research , AstraZeneca, Plc
Gregory Wiederrecht, Executive Director & Head, External Scientific A , Merck & Co, Inc
Description
The origins of biotechnology are rooted in academic research. The process of technology transfer and its evolution represents the ability of enlightened minds to work cooperatively to spin out novel technologies into start-up companies. Longterm strategic collaborations between industry and leading universities are a critical component of R&D.

Objective1:Update life science executives on the evolving sophistication of industry and academic collaboration with basics of technology transfer.

Objective2:Share ideas on best practices and pitfalls of industryacademic relations: what works and what to avoid.

Objective3:Highlight the growth in technology commercialization through examples of pharma and biotech collaboration.


Streaming Audio with
PowerPoint Slides
(Code: 559)
  
This session is a part of: